Academia and the Company Coin | Nature Biotechnology

Cecille Isidro — Fri, 01 May 2009 12:35:00 -0400

In some cases, the problem may be that industry is taking over more study designs and doing so with marketing in mind. “It’s about ‘How can we broaden out the uses of this drug, how can we promote it among more populations’… studies are marketing designs rather than public health designs. It doesn’t advance the body of evidence-based medicine in this country,” says Jennifer Washburn, author of University, Inc.: The Corporate Corruption of Higher Education and a fellow at the New